228 related articles for article (PubMed ID: 32029721)
1. Acetate supplementation restores chromatin accessibility and promotes tumor cell differentiation under hypoxia.
Li Y; Gruber JJ; Litzenburger UM; Zhou Y; Miao YR; LaGory EL; Li AM; Hu Z; Yip M; Hart LS; Maris JM; Chang HY; Giaccia AJ; Ye J
Cell Death Dis; 2020 Feb; 11(2):102. PubMed ID: 32029721
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma.
Jiang H; Greathouse RL; Tiche SJ; Zhao M; He B; Li Y; Li AM; Forgo B; Yip M; Li A; Shih M; Banuelos S; Zhou MN; Gruber JJ; Rankin EB; Hu Z; Shimada H; Chiu B; Ye J
Cancer Res; 2023 Jan; 83(2):181-194. PubMed ID: 36318118
[TBL] [Abstract][Full Text] [Related]
3. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy.
Anwar S; Shamsi A; Mohammad T; Islam A; Hassan MI
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188568. PubMed ID: 34023419
[TBL] [Abstract][Full Text] [Related]
4. Pyruvate dehydrogenase kinase 1 protects against neuronal injury and memory loss in mouse models of diabetes.
Yao Y; Shi J; Zhang C; Gao W; Huang N; Liu Y; Yan W; Han Y; Zhou W; Kong L
Cell Death Dis; 2023 Nov; 14(11):722. PubMed ID: 37935660
[TBL] [Abstract][Full Text] [Related]
5. Pyruvate dehydrogenase phosphatase 1 (PDP1) stimulates HIF activity by supporting histone acetylation under hypoxia.
Karagiota A; Kanoura A; Paraskeva E; Simos G; Chachami G
FEBS J; 2023 Apr; 290(8):2165-2179. PubMed ID: 36453802
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of pyruvate dehydrogenase kinase‑1 by dicoumarol enhances the sensitivity of hepatocellular carcinoma cells to oxaliplatin via metabolic reprogramming.
Xu H; He Y; Ma J; Zhao Y; Liu Y; Sun L; Su J
Int J Oncol; 2020 Sep; 57(3):733-742. PubMed ID: 32705170
[TBL] [Abstract][Full Text] [Related]
7. SIRT3 elicited an anti-Warburg effect through HIF1α/PDK1/PDHA1 to inhibit cholangiocarcinoma tumorigenesis.
Xu L; Li Y; Zhou L; Dorfman RG; Liu L; Cai R; Jiang C; Tang D; Wang Y; Zou X; Wang L; Zhang M
Cancer Med; 2019 May; 8(5):2380-2391. PubMed ID: 30993888
[TBL] [Abstract][Full Text] [Related]
8. Acetate supplementation induces growth arrest of NG2/PDGFRα-positive oligodendroglioma-derived tumor-initiating cells.
Long PM; Tighe SW; Driscoll HE; Moffett JR; Namboodiri AM; Viapiano MS; Lawler SE; Jaworski DM
PLoS One; 2013; 8(11):e80714. PubMed ID: 24278309
[TBL] [Abstract][Full Text] [Related]
9. Oral acetate supplementation attenuates N-methyl D-aspartate receptor hypofunction-induced behavioral phenotypes accompanied by restoration of acetyl-histone homeostasis.
Singh S; Choudhury A; Gusain P; Parvez S; Palit G; Shukla S; Ganguly S
Psychopharmacology (Berl); 2016 Apr; 233(7):1257-68. PubMed ID: 26832338
[TBL] [Abstract][Full Text] [Related]
10. ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid.
Wu JC; Jiang HM; Yang XH; Zheng HC
Cancer Med; 2018 Sep; 7(9):4554-4569. PubMed ID: 30091530
[TBL] [Abstract][Full Text] [Related]
11. The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance.
Woolbright BL; Choudhary D; Mikhalyuk A; Trammel C; Shanmugam S; Abbott E; Pilbeam CC; Taylor JA
Mol Cancer Ther; 2018 Sep; 17(9):2004-2012. PubMed ID: 29907593
[TBL] [Abstract][Full Text] [Related]
12. Rational combination with PDK1 inhibition overcomes cetuximab resistance in head and neck squamous cell carcinoma.
Lu H; Lu Y; Xie Y; Qiu S; Li X; Fan Z
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578313
[TBL] [Abstract][Full Text] [Related]
13. miR-128-3p contributes to mitochondrial dysfunction and induces apoptosis in glioma cells via targeting pyruvate dehydrogenase kinase 1.
Qu C; Yan C; Cao W; Li F; Qu Y; Guan K; Si C; Yu Z; Qu Z
IUBMB Life; 2020 Mar; 72(3):465-475. PubMed ID: 31828927
[TBL] [Abstract][Full Text] [Related]
14. Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance.
Lu CW; Lin SC; Chen KF; Lai YY; Tsai SJ
J Biol Chem; 2008 Oct; 283(42):28106-14. PubMed ID: 18718909
[TBL] [Abstract][Full Text] [Related]
15. Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis.
Kendrick SF; O'Boyle G; Mann J; Zeybel M; Palmer J; Jones DE; Day CP
Hepatology; 2010 Jun; 51(6):1988-97. PubMed ID: 20232292
[TBL] [Abstract][Full Text] [Related]
16. ACSS2-dependent histone acetylation improves cognition in mouse model of Alzheimer's disease.
Lin Y; Lin A; Cai L; Huang W; Yan S; Wei Y; Ruan X; Fang W; Dai X; Cheng J; Zhang J; Chen W; Ye Q; Chen X; Zhang J
Mol Neurodegener; 2023 Jul; 18(1):47. PubMed ID: 37438762
[TBL] [Abstract][Full Text] [Related]
17. Acetate promotes SNAI1 expression by ACSS2-mediated histone acetylation under glucose limitation in renal cell carcinoma cell.
Yao L; Jiang L; Zhang F; Li M; Yang B; Zhang F; Guo X
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32458971
[TBL] [Abstract][Full Text] [Related]
18. Local histone acetylation by ACSS2 promotes gene transcription for lysosomal biogenesis and autophagy.
Li X; Qian X; Lu Z
Autophagy; 2017 Oct; 13(10):1790-1791. PubMed ID: 28820290
[TBL] [Abstract][Full Text] [Related]
19. Cell surface GRP78 promotes tumor cell histone acetylation through metabolic reprogramming: a mechanism which modulates the Warburg effect.
Gopal U; Pizzo SV
Oncotarget; 2017 Dec; 8(64):107947-107963. PubMed ID: 29296215
[TBL] [Abstract][Full Text] [Related]
20. Influence of dichloroacetate (DCA) on lactate production and oxygen consumption in neuroblastoma cells: is DCA a suitable drug for neuroblastoma therapy?
Niewisch MR; Kuçi Z; Wolburg H; Sautter M; Krampen L; Deubzer B; Handgretinger R; Bruchelt G
Cell Physiol Biochem; 2012; 29(3-4):373-80. PubMed ID: 22508045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
